Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 885 | nsp12:L885I; | CL-3d; |
| 891 | nsp12:L891-; | CL-3a;CL-3b;CL-3c;CL-3d;CL-3e;CL-3f;CL-4; |
| 907 | nsp12:L907F; | CL-5; |
| 90 | nsp12:L90I; | CL-1a_3b;CL-3e; |
| 124 | nsp12:M124-; | CL-3b;CL-3e;CL-3f; |
| 124 | nsp12:M124V; | CL-1a;CL-3d;CL-3f; |
| 196 | nsp12:M196V; | CL-3f; |
| 242 | nsp12:M242L; | CL-3e; |
| 380 | nsp12:M380-; | CL-3b; |
| 380 | nsp12:M380V; | CL-3f; |
| 463 | nsp12:M463T; | CL-3b;CL-3e; |
| 463 | nsp12:M463V; | CL-3b;CL-3d; |
| 542 | nsp12:M542L; | CL-3b; |
| 566 | nsp12:M566-; | CL-3e; |
| 566 | nsp12:M566I; | CL-3d;CL-3e; |
| 615 | nsp12:M615-; | CL-3e;CL-3f; |
| 615 | nsp12:M615I; | CL-3e;CL-3f; |
| 615 | nsp12:M615V; | CL-1a_3d;CL-3b; |
| 629 | nsp12:M629V; | CL-3b; |
| 633 | nsp12:M633T; | CL-3b;CL-3e; |
| 633 | nsp12:M633V; | CL-2;CL-3e;CL-3f; |
| 666 | nsp12:M666-; | CL-3e; |
| 666 | nsp12:M666T; | CL-1a_3c;CL-3e; |
| 668 | nsp12:M668L; | CL-3d; |
| 794 | nsp12:M794V; | CL-3e; |
| 818 | nsp12:M818-; | CL-3b;CL-3e; |
| 818 | nsp12:M818L; | CL-1a; |
| 855 | nsp12:M855-; | CL-1a; |
| 902 | nsp12:M902I; | CL-3b;CL-3c; |
| 902 | nsp12:M902T; | CL-3f; |
| 906 | nsp12:M906V; | CL-1a_3a; |
| 924 | nsp12:M924-; | CL-1a_3e;CL-1b;CL-3b;CL-3c;CL-3e;CL-3f;CL-4; |
| 924 | nsp12:M924T; | CL-3f; |
| 924 | nsp12:M924Y; | CL-3e; |
| 138 | nsp12:N138-; | CL-3b;CL-3e; |
| 138 | nsp12:N138D; | CL-3d;CL-3f; |
| 138 | nsp12:N138K; | CL-3e; |
| 150 | nsp12:N150-; | CL-3c; |
| 150 | nsp12:N150S; | CL-1a;CL-3b;CL-3e; |
| 158 | nsp12:N158Y; | CL-3e; |
| 168 | nsp12:N168-; | CL-3e; |
| 198 | nsp12:N198D; | CL-3c; |
| 213 | nsp12:N213D; | CL-3c;CL-3f; |
| 213 | nsp12:N213K; | CL-3d; |
| 213 | nsp12:N213S; | CL-3b;CL-3e; |
| 215 | nsp12:N215-; | CL-3e; |
| 215 | nsp12:N215S; | CL-3b;CL-3e; |
| 297 | nsp12:N297S; | CL-3e; |
| 300 | nsp12:N300D; | CL-3b; |
| 300 | nsp12:N300S; | CL-2; |
Page 165 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com